相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Impact of Age at the Time o Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
Hee Sang Hwang et al.
CANCER RESEARCH AND TREATMENT (2021)
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
Tove Wasterlid et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older
Lucie Oberic et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Impact of relative dose intensity of standard regimens on survival in elderly patients aged 80 years and older with diffuse large B-cell lymphoma
Shin Lee et al.
HAEMATOLOGICA (2020)
Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma
Akihito Nagata et al.
HEMATOLOGICAL ONCOLOGY (2020)
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J. Nastoupil et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP
Masakazu Yamamoto et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
T. A. Eyre et al.
JOURNAL OF INTERNAL MEDICINE (2019)
The average relative dose intensity of R-CHOP is an independent factor determining favorable overall survival in diffuse large B-cell lymphoma patients
Monika Dlugosz-Danecka et al.
CANCER MEDICINE (2019)
The effect of R-CHOP dose reduction on overall survival of elderly patients with DLBCL - comparative study
Liat Vidal et al.
LEUKEMIA & LYMPHOMA (2018)
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study
Maja Bech Juul et al.
EUROPEAN JOURNAL OF CANCER (2018)
Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
Charlott Morth et al.
ANNALS OF HEMATOLOGY (2018)
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma
Toby A. Eyre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
Hyerim Ha et al.
CANCER RESEARCH AND TREATMENT (2016)
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma
Kenneth R. Carson et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
Hans Wildiers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
Frederic Peyrade et al.
LANCET ONCOLOGY (2011)
Importance of Relative Dose Intensity in Chemotherapy for Diffuse Large B-Cell Lymphoma
Hiroki Yamaguchi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2011)
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma
Tsuneaki Hirakawa et al.
ANNALS OF HEMATOLOGY (2010)
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
Yoshiki Terada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
A typology of reviews: an analysis of 14 review types and associated methodologies
Maria J. Grant et al.
HEALTH INFORMATION AND LIBRARIES JOURNAL (2009)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
